Pursuant to Regulation 26(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and in terms of captioned subject, it is ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.0 pts less than Nifty Microcap 250 and 6.5 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shree Pacetronix Limited has disclosed the recommendation of its Committee of Independent Directors (IDC) on an Open Offer made by Akash Sethi (Acquirer) along with three PACs (Atul Kumar Sethi, Amita Sethi, and Ashish Sethi), who are the existing Promoters and Promoter group. The Offer is to acquire up to 9,75,000 equity shares, representing 26% of the expanded share capital, at a price of ₹100 per share, aggregating to a total cash consideration of ₹9.75 crore. The IDC reviewed the Public Announcement, Detailed Public Statement, Draft Letter of Offer, and Letter of Offer, and unanimously opined that the Offer Price of ₹100 per share is fair and reasonable under SEBI (SAST) Regulations. The recommendation was published on October 28, 2025 in Financial Express, Jansatta, Navshakti, and Indore Samachar. Vivro Financial Services Private Limited is acting as the Manager to the Offer.
For public shareholders, this is an open offer from the existing promoter group to consolidate their holdings. The IDC has deemed the ₹100 per share offer price as fair and reasonable, though shareholders are advised to independently evaluate before tendering. The offer price and terms have been validated by independent directors, providing a degree of comfort, but the stock price reaction will depend on how the offer price compares with prevailing market levels.